The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.
 
Ranjit Singh Banwait
No Relationships to Disclose
 
Heidi Chwan Ko
Employment - LabCorp
Stock and Other Ownership Interests - Gilead Sciences; LabCorp
Honoraria - OncLive/MJH Life Sciences
 
Joel Michalek
No Relationships to Disclose
 
Kate Ida Lathrop
No Relationships to Disclose
 
Elizabeth Ann Bowhay-Carnes
Consulting or Advisory Role - Alnylam
Speakers' Bureau - Rigel
 
Georgios Fotopoulos
No Relationships to Disclose
 
Richard M. Elledge
No Relationships to Disclose
 
Anand B. Karnad
No Relationships to Disclose
 
Virginia G. Kaklamani
Honoraria - AstraZeneca; daichi; Genentech; Gilead Sciences; Novartis; Pfizer; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Lilly; Menarini; Puma Biotechnology; tersera; tersera
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Novartis; Pfizer
Research Funding - Eisai